All lobbying filings

CAPITOL COUNSEL LLC

CAPITOL COUNSEL LLC filed a Q3 report for IPSEN BIOPHARMACEUTICALS, INC. on October 19, 2026, reporting $30,000 in lobbying income.

Lobbying for IPSEN BIOPHARMACEUTICALS, INC. · Biopharmaceutical company.

All filings by CAPITOL COUNSEL LLC · Everything IPSEN BIOPHARMACEUTICALS, INC. has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 19, 2026

Income

$30,000

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Medicare/Medicaid

Ensure Medicare beneficiary access to Medicare covered prescription drugs and enable beneficiaries to spread cost-sharing requirements, including monitoring implementation of related provisions in the Inflation Reduction Act, P.L. 117-169.

Taxation/Internal Revenue Code

Issues related to international tax.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.